Vagally-Mediated Bradycardia Associated with Nasogastric Tube Insertion

Mechanism and Clinical Recognition

Vagal stimulation during nasogastric tube insertion can trigger bradycardia through increased parasympathetic tone, representing a physiologic reflex rather than intrinsic cardiac pathology, in patients undergoing the procedure 1
The American College of Cardiology notes that similar vagal responses occur during tracheal suctioning, laryngoscopy, and manipulation of regions innervated by the trigeminal nerve, in patients with various medical conditions 2, 3
Vagally-mediated bradycardia can be distinguished from pathologic bradycardia by the presence of concomitant sinus node slowing, and typically resolves spontaneously in patients after the procedure 1, 4

The American College of Cardiology recommends stopping tube advancement temporarily and allowing the patient to recover, ensuring adequate oxygenation and ventilation, as initial management for vagally-mediated bradycardia in patients 1
For patients with persistent bradycardia, the American College of Cardiology suggests administering atropine 0.5-1 mg IV, which can be repeated every 3-5 minutes up to a maximum of 3 mg, with an onset of action within 3 minutes after IV administration 5

Patients at higher risk for significant bradycardia during nasogastric tube insertion include those with age >60-65 years, baseline heart rate <60 bpm, concomitant use of beta-blockers, and American Society of Anesthesia Class III or IV comorbidities, according to the American College of Cardiology 1, 3, 5
The American College of Cardiology recommends considering prophylactic placement of transcutaneous pacing pads, reviewing and potentially holding negative chronotropic medications, having atropine immediately available, and monitoring heart rate continuously during tube insertion, as prevention strategies for high-risk patients 1, 3, 5